JME Group, Inc. is a privately held, biotechnology company founded on March 2014 in New Jersey, U.S.

The company embarked on a project to develop and commercialize a safer and affordable enzyme replacement therapy (ERT) for metabolic and lysosomal storage diseases (a group of rare (orphan) diseases deficient in lysosomal enzymes) via oral administration (hence Oral-ERT) using plant-derived recombinant human enzymes or proteins plus natural non-GMO plant products for improvement of human and animal health. The first enzyme in the pipeline using this platform is a recombinant human lysosomal acid alpha-glucosidase (GAA) or acid maltase produced in tobacco seeds for the treatment of acid maltase deficiency (AMD or POMPE disease).

JME GROUP Inc

Org chart

Teams

Offices

JME GROUP Inc

Org chart

Teams

Offices

Related companies